Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product. - Wikidata - wikimedia - TriplyDB

Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product.

Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product.

http://www.wikidata.org/entity/Q34932706

about

The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques Preformulation studies of EFdA, a novel nucleoside reverse transcriptase inhibitor for HIV prevention.The chemistry and biology of theta defensins.Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery.Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV prevention Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide.Assessing the potential of the Woman's Condom for vaginal drug delivery Microbicides for the Treatment of Sexually Transmitted HIV Infections.Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture.Natural antimicrobial peptides as promising anti-HIV candidates.Antiviral activity of retrocyclin RC-101, a candidate microbicide against cell-associated HIV-1 Retrocyclins neutralize bacterial toxins by potentiating their unfolding.Current and future microbicide approaches aimed at preventing HIV infection in women.Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties.The Role of Defensins in HIV Pathogenesis.On-demand microbicide products: design matters.Topical delivery of low-cost protein drug candidates made in chloroplasts for biofilm disruption and uptake by oral epithelial cells.θ-Defensins: cyclic peptides with endless potential.Antifungal Activity of the Noncytotoxic Human Peptide Hepcidin 20 against Fluconazole-Resistant Candida glabrata in Human Vaginal Fluid.

P2860

Q27000032-F6C25242-97A8-4C1C-A1B6-39E2BDBFBBC3 Q30412592-C11491A2-B7CA-483F-98F7-BA3BED9E2EAA Q33760642-D1881975-AA81-4745-96A1-5E0D3EF5B0A1 Q34059879-769E8845-ED72-48E2-847D-B44AB92E8AA7 Q34431648-F0CA5219-F45E-4DFB-AD07-A7171093D343 Q34604290-7E6FBBD5-3E5F-43E2-B25F-F8C8536023A6 Q35002085-6637427C-27F4-481F-A70D-FF0D5F02689A Q35426599-EBFE865A-4C4B-4A54-B878-DBDF3AFB62A3 Q36039442-0292F7C2-26B5-47F6-80E4-97C7966424A3 Q36112191-40A8DA6F-8D81-4DD2-BD92-8FE247A7D084 Q36113575-03B5EBAF-A6B5-4DF3-8036-0C328873DCB5 Q36514316-751FE1BF-5E29-4A3F-BD36-3589C2DDD57A Q36553945-D205927C-560C-4E92-B16E-B623E14945CF Q37545884-179EA840-15A7-4DEC-B924-12032E6740E6 Q37984498-4737696F-93FA-4950-B0F2-E632EFA520C1 Q38285790-0FEAEA08-501B-430C-9E57-10330DE62D0C Q38637503-4E3F0CEE-DC37-4533-8E27-B3FEC9E07343 Q39356290-849F9007-4666-4833-A642-6736EE0727DB Q41819296-8E7A2BD1-10CA-422D-8A03-48A437E5F192 Q42260251-D3D813A0-32F7-4802-BC56-9E4804F76790 Q42573057-CC34D97F-6402-49D9-AE74-96CC8C0B42A0

P2860

Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product.

http://www.wikidata.org/entity/Q34932706

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Formulation development of ret ...... V vaginal microbicide product.

@ast

Formulation development of ret ...... V vaginal microbicide product.

@en

Formulation development of ret ...... V vaginal microbicide product.

@nl

type

label

Formulation development of ret ...... V vaginal microbicide product.

@ast

Formulation development of ret ...... V vaginal microbicide product.

@en

Formulation development of ret ...... V vaginal microbicide product.

@nl

prefLabel

Formulation development of ret ...... V vaginal microbicide product.

@ast

Formulation development of ret ...... V vaginal microbicide product.

@en

Formulation development of ret ...... V vaginal microbicide product.

@nl

P1433

Q34932706-C97B53BE-1035-4AF1-AB59-209C08F6ADB8

P1476

Q34932706-C20C1A25-0F74-4A02-A77A-C6FB519E6F48

P2093

Q34932706-08B7294A-032F-4DE7-9E9C-4E377C7EBC76

Q34932706-17BF3F15-8797-4EE4-BDF2-55A09038A341

Q34932706-2AC09A1A-8D12-4050-BD63-A70FF6B04EE9

Q34932706-8D55C361-778B-4FC8-8024-9189219A3BB3

Q34932706-C4D5B7D2-7A33-4644-91F2-134D76BC177A

Q34932706-EB998E75-D6A2-4BF4-B01E-9614D434D5B0

Q34932706-F52A90E5-319B-43EF-8F34-2271FAB57A1F

P2860

Q34932706-0F8AA978-30B4-49EB-A5F1-59901CDDE39B

Q34932706-25D31871-33A3-4161-8394-26B161B27A9A

Q34932706-37138673-549E-4BB6-9841-80E92E11697D

Q34932706-3AFAB475-E191-4739-A6E9-4AE8A3A38D27

Q34932706-43EB6F81-0BD2-49B0-863D-C11E83A21C22

Q34932706-4CA9D2A8-DBF6-482B-8B4C-0622CED166B3

Q34932706-4DD4897C-9845-4CB5-8A79-A15431B7A522

Q34932706-52B03C03-D9E7-4070-A5D7-AE6FF45B4AA8

Q34932706-5396079B-C451-4D78-B91C-55A5626023EE

Q34932706-587369C8-6D0A-413B-8791-BA2637DE7BA0

P304

Q34932706-0353268D-9FBA-4D76-96AC-C10F9713B570

P31

Q34932706-9555F784-19E3-4FBE-A92A-023BE0146696

P356

Q34932706-0F6E8D0E-9521-430D-81A8-626C99CC2B55

P407

Q34932706-24B8D6FF-811E-466E-B965-75F09733DA65

P433

Q34932706-18F3026B-4BE4-47A9-A68A-A76A652B4426

P478

Q34932706-7B3F1CE7-5BBD-4D49-A317-FC0943C332FE

P577

Q34932706-C06BC92D-75B5-4A43-BBB6-FF82C9389AFC

P698

Q34932706-A22DF304-5104-4ECC-A51C-B621B39C7F64

P932

Q34932706-6413CE21-F1C9-4D04-B76C-7F6F2423C6D1

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Formulation development of ret ...... V vaginal microbicide product.

@en

P2093

A B Sassi

http://www.w3.org/2001/XMLSchema#string

A L Cole

http://www.w3.org/2001/XMLSchema#string

A M Cole

http://www.w3.org/2001/XMLSchema#string

D L Patton

http://www.w3.org/2001/XMLSchema#string

L C Rohan

http://www.w3.org/2001/XMLSchema#string

M R Cost

http://www.w3.org/2001/XMLSchema#string

P Gupta

http://www.w3.org/2001/XMLSchema#string

P2860

Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system.

A novel itraconazole bioadhesive film for vaginal delivery: design, optimization, and physicodynamic characterization.

A vaginal fluid simulant.

The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques

Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.

New delivery systems in contraception: vaginal rings.

Retrocyclin, an antiretroviral theta-defensin, is a lectin.

Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.

Development pharmaceutics of microbicide formulations. Part I: preformulation considerations and challenges.

Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challenges.

P304

2282-2289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01190-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21321138

http://www.w3.org/2001/XMLSchema#string

P932

3088226

http://www.w3.org/2001/XMLSchema#string